Contribution of immunological and virological factors to extremely severe primary HIV type 1 infection.
about
Clinical significance of HIV-1 coreceptor usage.X4 tropic multi-drug resistant quasi-species detected at the time of primary HIV-1 infection remain exclusive or at least dominant far from PHIViremic HIV infected individuals with high CD4 T cells and functional envelope proteins show anti-gp41 antibodies with unique specificity and functionReplicative capacity of human immunodeficiency virus type 1 transmitted from mother to child is associated with pediatric disease progression rateHost and viral genetic correlates of clinical definitions of HIV-1 disease progression.A case of seronegative HIV-1 infection.Pathogenesis and treatment of HIV infection: the cellular, the immune system and the neuroendocrine systems perspective.Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque.Acute retroviral syndrome and high baseline viral load are predictors of rapid HIV progression among untreated Argentinean seroconverters.Rapid HIV progression during acute HIV-1 subtype C infection in a Mozambican patient with atypical seroconversionIn-depth characterization of viral isolates from plasma and cells compared with plasma circulating quasispecies in early HIV-1 infection.Human Immunodeficiency Virus (HIV).A case cluster demonstrating the relationship between HLA concordance and virologic and disease outcomes in human immunodeficiency virus infection.Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved?[Human immunodeficiency virus: position of Blood Working Group of the Federal Ministry of Health].
P2860
Q27691426-188924E1-A96C-439D-B1A7-E9FEB9F12ED3Q28476667-7649487F-FB2A-4C4D-8330-CD8A764F57C6Q28732293-3D845728-9DC4-4E44-88A4-C4B74987A6D7Q33558599-4FD5AF76-3B45-40AC-9E99-5C9CA5E17D0CQ33605758-0971D16C-FDC2-411C-9BAD-6DE1DD0414B9Q33652601-D36DBCCB-E5F6-43EB-B96F-5E747BD5D5BCQ34650866-CC0873E8-B80F-4F80-83A8-FDC013469FE1Q35015712-6CBE1C49-583F-465B-96F8-2361972E60C8Q35231130-503D791B-AEAA-438B-8262-15B8DE6F662EQ35272468-E1B716D1-55E2-49DC-96BF-C20F884C2791Q35790802-F7C44B97-44BD-416B-932A-4D424E2060CFQ37045832-7BB3F83A-3605-4CF8-B763-074AF861F27DQ37492352-AC87B609-E8F3-4B1F-92AF-90CE9CC4A12FQ40919867-9DD5BC75-7631-4E71-AC9C-632536BAF49AQ40942917-99892CF3-5BFA-4809-A54A-7D1E6F4DE4B3
P2860
Contribution of immunological and virological factors to extremely severe primary HIV type 1 infection.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Contribution of immunological ...... primary HIV type 1 infection.
@ast
Contribution of immunological ...... primary HIV type 1 infection.
@en
Contribution of immunological ...... primary HIV type 1 infection.
@nl
type
label
Contribution of immunological ...... primary HIV type 1 infection.
@ast
Contribution of immunological ...... primary HIV type 1 infection.
@en
Contribution of immunological ...... primary HIV type 1 infection.
@nl
prefLabel
Contribution of immunological ...... primary HIV type 1 infection.
@ast
Contribution of immunological ...... primary HIV type 1 infection.
@en
Contribution of immunological ...... primary HIV type 1 infection.
@nl
P2093
P2860
P50
P356
P1476
Contribution of immunological ...... primary HIV type 1 infection.
@en
P2093
Ana Mariño
Judith Dalmau
Lourdes Matas
Marta Azuara
Nicole Frahm
Roger Paredes
Todd M Allen
P2860
P304
P356
10.1086/595704
P407
P50
P577
2009-01-01T00:00:00Z